CASP8 and medulloblastoma: Methylation of the CASP8 gene has been associated with low levels of caspase-8 expression, reduced response to chemotherapeutic agents and poor outcome in a number of different cancer types including medulloblastoma [24] and neuroblastoma [25], [26], although this remains controversial at least in neuroblastoma [27].